These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


689 related items for PubMed ID: 16618397

  • 1. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.
    Jess T, Loftus EV, Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC, Schleck CD, Tremaine WJ, Melton LJ, Munkholm P, Sandborn WJ.
    Gastroenterology; 2006 Apr; 130(4):1039-46. PubMed ID: 16618397
    [Abstract] [Full Text] [Related]

  • 2. Risk of lymphoma in inflammatory bowel disease.
    Loftus EV, Tremaine WJ, Habermann TM, Harmsen WS, Zinsmeister AR, Sandborn WJ.
    Am J Gastroenterol; 2000 Sep; 95(9):2308-12. PubMed ID: 11007233
    [Abstract] [Full Text] [Related]

  • 3. Cancer in patients with ulcerative colitis, Crohn's disease and coeliac disease: record linkage study.
    Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Jewell D.
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):297-304. PubMed ID: 18334873
    [Abstract] [Full Text] [Related]

  • 4. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K, Tulassay Z.
    Orv Hetil; 2006 Oct 15; 147(41):1977-82. PubMed ID: 17120688
    [Abstract] [Full Text] [Related]

  • 5. [Colorectal cancer in inflammatory bowel disease].
    Henriksen M, Moum B.
    Tidsskr Nor Laegeforen; 2007 Oct 18; 127(20):2696-9. PubMed ID: 17952155
    [Abstract] [Full Text] [Related]

  • 6. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH, Vermeire S, Christodoulou DK, Riis L, Wolters F, Odes S, Freitas J, Hoie O, Beltrami M, Fornaciari G, Clofent J, Bodini P, Vatn M, Nunes PB, Moum B, Munkholm P, Limonard C, Stockbrugger R, Rutgeerts P, Tsianos EV, EC-IBD Study Group.
    Digestion; 2007 Oct 18; 75(2-3):113-21. PubMed ID: 17598963
    [Abstract] [Full Text] [Related]

  • 7. Non-calculus suppurative cholangitis in Danish patients with inflammatory bowel disease.
    Rasmussen HH, Nørgård B, Olsen ML, Fonager K, Sørensen HT.
    Hepatogastroenterology; 2005 Oct 18; 52(61):115-8. PubMed ID: 15783009
    [Abstract] [Full Text] [Related]

  • 8. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies.
    Jess T, Gamborg M, Matzen P, Munkholm P, Sørensen TI.
    Am J Gastroenterol; 2005 Dec 18; 100(12):2724-9. PubMed ID: 16393226
    [Abstract] [Full Text] [Related]

  • 9. Ulcerative colitis and colorectal cancer. A population-based study.
    Ekbom A, Helmick C, Zack M, Adami HO.
    N Engl J Med; 1990 Nov 01; 323(18):1228-33. PubMed ID: 2215606
    [Abstract] [Full Text] [Related]

  • 10. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease.
    Canavan C, Abrams KR, Mayberry J.
    Aliment Pharmacol Ther; 2006 Apr 15; 23(8):1097-104. PubMed ID: 16611269
    [Abstract] [Full Text] [Related]

  • 11. Early measles virus infection is associated with the development of inflammatory bowel disease.
    Pardi DS, Tremaine WJ, Sandborn WJ, Loftus EV, Poland GA, Harmsen WS, Zinsmeister AR, Melton LJ.
    Am J Gastroenterol; 2000 Jun 15; 95(6):1480-5. PubMed ID: 10894583
    [Abstract] [Full Text] [Related]

  • 12. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Gut; 2008 Nov 15; 57(11):1518-23. PubMed ID: 18566104
    [Abstract] [Full Text] [Related]

  • 13. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Nov 15; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
    Jess T, Loftus EV, Velayos FS, Winther KV, Tremaine WJ, Zinsmeister AR, Scott Harmsen W, Langholz E, Binder V, Munkholm P, Sandborn WJ.
    Am J Gastroenterol; 2007 Apr 15; 102(4):829-36. PubMed ID: 17222314
    [Abstract] [Full Text] [Related]

  • 15. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
    Maykel JA, Hagerman G, Mellgren AF, Li SY, Alavi K, Baxter NN, Madoff RD.
    Dis Colon Rectum; 2006 Jul 15; 49(7):950-7. PubMed ID: 16729218
    [Abstract] [Full Text] [Related]

  • 16. The prognosis of inflammatory bowel disease.
    Sales DJ, Kirsner JB.
    Arch Intern Med; 1983 Feb 15; 143(2):294-9. PubMed ID: 6824395
    [Abstract] [Full Text] [Related]

  • 17. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study.
    Limburg PJ, Vierkant RA, Fredericksen ZS, Leibson CL, Rizza RA, Gupta AK, Ahlquist DA, Melton LJ, Sellers TA, Cerhan JR.
    Am J Gastroenterol; 2006 Aug 15; 101(8):1872-9. PubMed ID: 16790032
    [Abstract] [Full Text] [Related]

  • 18. The risk of cancer in patients with Crohn's disease.
    von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP.
    Dis Colon Rectum; 2007 Jun 15; 50(6):839-55. PubMed ID: 17308939
    [Abstract] [Full Text] [Related]

  • 19. Cancer and pediatric inflammatory bowel disease.
    Kayton ML.
    Semin Pediatr Surg; 2007 Aug 15; 16(3):205-13. PubMed ID: 17602977
    [Abstract] [Full Text] [Related]

  • 20. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
    Lindström L, Lapidus A, Ost A, Bergquist A.
    Dis Colon Rectum; 2011 Nov 15; 54(11):1392-7. PubMed ID: 21979184
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 35.